I never said Novartis walked away because the meeting went badly. To the contrary, I (wrongly) guessed the meeting had not occurred.
I said Novartis walked away because the data stank.
But, given there is still no clarity despite the looooong awaited meeting, you can hardly say this is a good announcement. So it might have been they walked because they didn’t like what occurred in the meeting
. Still heaps more work to be done and still 15 days to go before all doubt is removed.
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD, page-91
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |